medigraphic.com
Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado

2017, Number 3

<< Back

Rev Esp Med Quir 2017; 22 (3)

Interventional management for phantom limb pain refractory to pharmacological management: case report

Criollo-Muñoz FH, Hernández-Santos JR, Torres-Huerta JC

Language: Spanish
References: 15
Page: 131
PDF size: 983.15 Kb.


ABSTRACT

Introduction: The non-implantable interventional management of phantom limb pain has reported few positive medium and long term control pain results, so it remains a controversial management.
Objective: To report the medium-term efficacy of non-implantable interventional treatment in two cases of refractory phantom limb pain to drug treatment.
Methods: Two cases of phantom limb pain refractory to drug treatment were selected between March and June 2015, with pain neuropathic features of severe intensity, which were managed with non-implantable interventional treatment (foraminal block L3-S1 right and epidural block T3-T6). Once the procedure was performed in each patient, monitoring the intensity of pain according to the visual analog scale (VAS) was performed at the 1st, 4th week, and the 2nd, 3rd, 4th and 5th month.
Results: Two cases of phantom limb pain were obtained: amputation of the right pelvic limb (case 1) and right mastectomy (case 2), both with more than 7/10 initial EVA and EVA later with 2-3/10, after the interventional procedure was performed a 5 months follow up.
Conclusions: In both cases the procedures performed were considered effective in relieving pain in the medium term. These procedures could be considered as a management option in cases refractory to pharmacologic treatment.


REFERENCES

  1. Keil G. Sogenannte Erstbeschreibung des Phantomschmerzes von Ambroise Paré. Fortschritte der Medicine, 1990.

  2. Flor H. Phantom-limb pain: characteristics, causes and treatment. Lancet. 2002;1:182-9.

  3. McCormick Z, Chang-Chien G, Marshall B, et al. Phantom limb pain: A Systematic neuroanatomical-based review of pharmacologic treatment. Pain Medicine. 2014;15:292-305.

  4. Manchikanti L, Singh V. Managing phantom pain. Pain Physician. 2004;7(3): 365-375.

  5. Smith BH, Torrance N, Ferguson JA, et al. Towards a definition of refractory neuropathic pain for epidemiological research. An international Delphi survey of experts. BMC Neurol. 2012;12:29.

  6. Cohen S, Gambel J, Raja S, et al.The contribution of sympathetic mechanisms to postamputation phantom and residual limb pain: a pilot study. J Pain. 2011;12(8):859-67.

  7. Raj P, Lou L, Erdine S, et al. Interventional pain management: image guided procedures, Second edition. Saunders, an imprint of Elsevier Inc, 2008.

  8. Malavera M, Carrillo S, Gomezese O, et al. Pathophysiology and treatment of phantom limb pain. Rev Colomb Anestesiol. 2014;42(1):40-6.

  9. Sumitani M, Miyauchi S, Yozu A, et al. Phantom limb pain in the primary motor cortex: topical review. J Anesth. 2010;24:337-41.

  10. Wolff A, Vanduynhoven E, van Kleef M, et al. Phantom pain: evidence based medicine. Pain Pract. 2011;11(4):403-13.

  11. Huse E, Larbig Wa, Flor H, et al. The effect of opioids on phantom limb pain and cortical reorganization. Pain. 2001;90(1-2):47-55.

  12. Bach S, Noreng MF, Tjellden NU. Phantom limb pain in amputees during the first 12 months following limb amputation, after preoperative lumbar epidural blockade. Pain. 1988;33(3):297-301.

  13. Jahangiri M, Jayatunga AP, Bradley JWP, et al. Prevention of phantom pain after major lower limb amputation by epidural infusion of diamorphine, clonidine, and bupivacaine. Ann R Coll Surg Engl. 1994;76:324.

  14. Nikolajsen L, Ilkjær S, Christensen JH, et al. Randomised trial of epidural bupivacaine and morphine in prevention of stump and phantom pain in lower-limb amputation. Lancet. 1997;350(9088):1353-7.

  15. Halbert J, Crotty M, Cameron ID. Evidence for the optimal management of acute and chronic phantom pain: A systematic review. Clin J Pain. 2002;18(2): 84-92.




2020     |     www.medigraphic.com